Latest News & Features
Americas
The dominant player in the spatial biology market has sued a San Diego-based life sciences company over its genetic analysis technology, as another lawsuit in its patent litigation campaign approaches conclusion. 12 May 2026
Americas
Trade secret filings in the US reached an all-time high in 2025—particularly those relating to AI. Jeff Farrow of Michelman Robinson explains the principles that courts are increasingly applying, and how companies on both sides of the ‘v’ can prepare. 11 May 2026
Americas
LSIPR's senior reporter Marisa Woutersen speaks with Mythili Markowski of Regeneron on why new USPTO guidance is putting post-grant proceedings under the spotlight and how in-house teams are responding. 8 May 2026
Europe
Experts from Johnson & Johnson and Novartis took the stage at INTA to share the pitfalls lurking inside mergers, acquisitions and spin-offs and what in-house counsel can do about them. 7 May 2026
Americas
A California judge has denied Corcept’s bid to dismiss the lawsuit over its drug for a rare hormonal disorder, allowing the litigation to proceed on all core counts. 7 May 2026
Europe
Panellists at INTA share how workplaces can bridge generational divides and why those differences may be a team’s biggest strengths. 6 May 2026
Careers
The new partner, a former entrepreneur and self-proclaimed ‘hardcore programmer’, brings patent litigation savvy to the firm. 6 May 2026
Americas
J&J’s Abiomed can proceed with its non-infringement defence despite potential future appellate reversal, in a week when both parties in the case were dealt wins and losses in their clash over Impella devices. 5 May 2026
Europe
John Ward, vice president and associate general counsel of trademarks at Moderna, chats with Tom Phillips at INTA 2026. 5 May 2026
Americas
LSIPR's senior reporter Marisa Woutersen speaks with Ben Doranz of Integral Molecular, fresh from the stage at LSPN Boston after speaking at a panel session on challenges in antibody patent protection. 4 May 2026